Parkinson's Disease
description
Transcript of Parkinson's Disease
Presented by
Jessica Faye Manansala
Parkinson's Disease
Is a slowly progressing neurologic movement disorder that eventually leads to disability.
Symptoms 1st appear in 50th decade of lifeParkinson’s disease may be diagnosed at the
aged of 30PD is the 4th most common neurodegenerative
disease.It affects men more frequently than women.
Most cause was unknown
Parkinson's Disease
GeneticAtheriosclerosisHead traumaChronic antipsychotic medsExcessive accumulation of O2Viral infectionAnd some environmental exposure
Factors
Pathophysiology
THREE CARDINAL SIGNS1. Tremor2. Rigidity3. Bradykinesia (abnormally slow movement)Other signs Hypokinesia Gait disturbances Postural instability
Clinical Manifestation
Tremor – rhythmic , slow turning motion of the forearm & hand and a motion of the thumb against the finger as if a rolling pill.
- Present while the pt. is at rest- Tremor increase when the pt. is walking,
concentrating or feeling anxious.Rigidity – resistance to passive limb
movement “cogwheeling” passive movement- Stiffness of the neck, trunk & shoulder is
common.- The pt. may complain shoulder pain (early
signs).Bradykinesia - abnormally slow movementHypokinesia (abnormally diminished
movement) – common appear after tremor
Micrographia – shrinking, slow hand writingDysphonia – soft, slurred, low pitched, and less
audible speech.Shuffling gait – the pt. may walk faster and
faster, trying to move the feet forward under the body’s center of gravity.
Other manifestationsExcessive & uncontrolled sweatingProxysmal flushingGastric & urinary retentionOrthhostatic hypothensionConstipationDementiaDepression
PET (Positron emission tomography)scanning – used in evaluating levodopa (precursor of dopamine) uptake and conversion to dopamine.
Patients historyPresence of 2 or 3 cardinal signs
Diagnosis
Antiparkinsonian medications – levodopa (dopar, larodopa) with the combination of carbidopa (sinemet)
- Budipine – non-dopaminergic, atiparkinsonian medication (it reduces akinesia, rigidity and tremor)
Anticholinergic therapy – (trihexyphenidyl, cycrimine, procyclidine, biperiden and benztropine mesylate) effective for controlling tremor and rigidity.
Antiviral therapy – amantadine hydrochloride (symmetrel)
- It release dopamine from neuronal sites it has also a low incidence of side effect
Medical management
Dopamine agonist – bromocriptine mesylate (parlodel) and pergolide (permax). Ergot derivatives
- This are dopamine receptor agonist and are useful in postponing the initiation of carbidopa or levodopa therapy.
MAO inhibitors – selegiline (eldepryl)- It inhibits dopamine breakdown and is thought to
slow the progression of the disease.- Selegiline used w/ the combination of dopamine
agonist to delay the use carbidopa or levodopa therapy.
COMT inhibitor (catecol-O-methyltransferase) – comtess and tasmar
- COMT block the enzyme that metabolizes levodopa, amking more levodopa more available for conversion to dopamine in the brain.
Antidepressant – tricyclic antidepressant may be prescribe to alleviate the depression that is so common in parkinson’s disease.
Antihistamine – benadryl, banflex, neo-synephrine have mild central anticholinergic and sedative effects and may reduce tremors.
SURGICAL MANAGEMENTStereotactic procedures – thalamotomy and
pallidotomy are effective in relieving PD symptoms
- pt. with dimentia and atypical parkinson disease are usually not considered for this procedure
- Thalamotomy and pallidotomy is to interrupt the nerve pathways and thereby alleviate tremor or ridigity.
Neural transplantation – surgical implantation of adrenal medulary tissue into the corpus striatum to reestablish normal dopamine release.
Deep brain stimulation – pacemaker like brain implant
- An electrode is placed in the thalamus and connected to a pulse generator implanted in a subcutaneous subclavicular or abdominal pouch. The battery powered pulse generator send high frequency electrical impulses through a wire placed under the skin to a lead anchored to skull
- The electrode blocks nerve pathways in the brain that cause tremors.
THE END